drugset / Trial / NCT03748108
Bolus Administration of Intravenous Lidocaine at the Time of Abdominal Hysterectomy
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The objective of the study to evaluate whether a bolus administration of intravenous lidocaine decreases postoperative pain and represents an opioid-minimizing strategy after abdominal hysterectomy compared with placebo.
Timeline
- Start
- 2018-12-01
- Primary completion
- 2020-03-30
- Completion
- 2020-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 1.5 mg/kg | Intravenous |
Indications
No indication recorded.